DoJ Copaxone Kickback Suit ‘Flawed’ And An ‘Overreach,’ Teva Says

Teva was accused by the US Department of Justice of violating anti-kickback law in donating money to charities that was later used to cover patient co-pays for Copaxone. In a rebuke aimed at having the suit dismissed, the Israeli manufacturer labelled the DoJ’s suit as “fatally flawed.”